Citi Starts Mirum Pharmaceuticals (MIRM) at Buy Jun 2, 2026 05:01AM
Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens Jun 1, 2026 04:43AM
Mirum presents new data on rare liver disease treatments at EASL congress Jun 1, 2026 02:53AM
Wolfe Research Starts Mirum Pharmaceuticals (MIRM) at Outperform May 19, 2026 05:33AM
Mirum Pharmaceuticals (MIRM) PT Raised to $129 at Baird May 7, 2026 04:28AM
View Older Stories

May 6, 2026 04:20PM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q1 EPS by 1309c ; Offers Guidance
May 4, 2026 09:41AM Baird Reiterates Outperform Rating on Mirum Pharmaceuticals (MIRM)
May 4, 2026 08:45AM Mirum Pharmaceuticals (MIRM) PT Raised to $135 at Evercore ISI
May 4, 2026 08:01AM Mirum reports volixibat meets primary endpoint in cholangitis study
Apr 28, 2026 05:05PM Mirum Pharmaceuticals (MIRM) PT Raised to $130 at Stifel
Apr 27, 2026 11:21AM Mirum Pharmaceuticals (MIRM) PT Raised to $112 at Baird
Apr 27, 2026 10:02AM Mirum Pharmaceuticals (MIRM) PT Raised to $150 at H.C. Wainwright
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 10, 2026 08:01AM Mirum Pharmaceuticals (MIRM) Reiterated at Overweight by Cantor Fitzgerald
Mar 27, 2026 06:24AM Mirum Pharmaceuticals (MIRM) PT Raised to $125 at TD Cowen
Mar 26, 2026 04:41AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens
Mar 23, 2026 08:12AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens
Mar 17, 2026 05:30AM Citizens Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM)
Mar 5, 2026 09:18AM Morgan Stanley Reiterates Overweight Rating on Mirum Pharmaceuticals (MIRM) amid study enrollment, screening completion
Mar 4, 2026 08:27AM Mirum Pharmaceuticals (MIRM) PT Raised to $126 at Evercore ISI
Feb 26, 2026 10:52AM Mirum Pharmaceuticals (MIRM) PT Lowered to $118 at Leerink Partners
Feb 26, 2026 10:50AM Mirum Pharmaceuticals (MIRM) Defended by Second Outlet, This time from Evercore: 'we think the move down is noise in a volatile tape this morning.'
Feb 26, 2026 10:40AM RBC Capital Defending Mirum Pharmaceuticals (MIRM) Amid 15% Drop: 'Buying Opportunity Ahead of Multiple De-risked Catalysts'
Feb 26, 2026 04:49AM Mirum Pharmaceuticals (MIRM) PT Lowered to $132 at Citizens: Has Strong Momentum
Feb 5, 2026 08:52AM Mirum receives Health Canada approval for LIVMARLI tablet formulation
Feb 5, 2026 08:01AM Mirum Pharmaceuticals receives Health Canada approval for LIVMARLI treatment
Jan 26, 2026 06:49AM Mirum Pharmaceuticals (MIRM) PT Raised to $130 at H.C. Wainwright
Jan 15, 2026 04:16AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform: 'Top Pick' at Citizens
Jan 12, 2026 02:36PM Mirum Pharmaceuticals (MIRM) PT Raised to $95 at Baird
Jan 12, 2026 09:50AM TD Cowen on Mirum Pharmaceuticals (MIRM): 'Remain at Buy for base business and pipeline'
Jan 12, 2026 08:31AM Mirum Pharmaceuticals reports preliminary 2025 sales of $520 million
Jan 9, 2026 11:55AM Mirum launches phase 2 trial for Fragile X syndrome treatment
Dec 19, 2025 04:08PM Mirum sues generic drugmakers over Livmarli patent infringement
Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'
Dec 19, 2025 04:33AM Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expected
Dec 19, 2025 04:33AM Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expeected
Dec 11, 2025 06:38AM Mirum Pharmaceuticals (MIRM) PT Raised to $110 at Raymond James
Dec 10, 2025 02:38PM Mirum Pharmaceuticals (MIRM) PT Raised to $100 at Leerink Partners
Dec 9, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)
Dec 9, 2025 04:24AM Leerink Partners: 'MIRM’s Bluejay Deal Nice External Recognition of HDV Value; Positive for VIR'
Dec 8, 2025 03:52PM Mirum Pharmaceuticals (MIRM) PT Raised to $94 at Evercore ISI
Dec 8, 2025 03:01PM Morgan Stanley: 'we view the HDV program as promising and we view the transaction as a good fit for Mirum'
Dec 8, 2025 03:00PM Mirum Pharmaceuticals (MIRM) PT Raised to $88 at Baird
Nov 7, 2025 08:11AM Mirum presents liver disease drug data at AASLD conference
Nov 5, 2025 05:01AM Mirum Pharmaceuticals (MIRM) PT Raised to $95 at Citizens, Remains A Favorite
Nov 4, 2025 11:44PM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 20c ; Offers Guidance
Sep 24, 2025 03:20AM TD Cowen Starts Mirum Pharmaceuticals (MIRM) at Buy
Sep 17, 2025 04:16AM Citizens JMP Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM)
Aug 12, 2025 04:10PM Mirum Pharmaceuticals, Inc. (MIRM) Files Mixed Shelf
Aug 11, 2025 05:48AM Stifel Resumes Mirum Pharmaceuticals (MIRM) at Buy, PT $89, 'stands out in what remains a discerning biotech tape'
Aug 7, 2025 07:18AM Mirum Pharmaceuticals (MIRM) PT Raised to $80 at H.C. Wainwright
Aug 7, 2025 04:17AM Mirum Pharmaceuticals (MIRM) PT Raised to $81 at Citizens JMP
Aug 6, 2025 04:11PM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q2 EPS by 21c
May 19, 2025 08:52AM Mirum Pharmaceuticals, Inc. (MIRM) appoints Doug Sheehy as CLO
May 19, 2025 06:44AM H.C. Wainwright Starts Mirum Pharmaceuticals (MIRM) at Buy
View Older Stories